CN Patent

CN118251400A — Axl激酶抑制剂的盐、其制备方法和用途

Assigned to Nanjing Chia Tai Tianqing Pharmaceutical Co Ltd · Expires 2024-06-25 · 2y expired

What this patent protects

本发明提供了一种式I化合物的盐以及盐的晶型，及其制备方法和用途。其中所述盐选自甲磺酸盐、苯磺酸盐、草酸盐、富马酸盐、柠檬酸盐、马尿酸盐、盐酸盐、氢溴酸盐、硫酸盐或磷酸盐。

USPTO Abstract

本发明提供了一种式I化合物的盐以及盐的晶型，及其制备方法和用途。其中所述盐选自甲磺酸盐、苯磺酸盐、草酸盐、富马酸盐、柠檬酸盐、马尿酸盐、盐酸盐、氢溴酸盐、硫酸盐或磷酸盐。

Drugs covered by this patent

quizartinib-dihydrochloride (QUIZARTINIB DIHYDROCHLORIDE)

Patent Metadata

Patent number: CN118251400A
Jurisdiction: CN
Classification: —
Expires: 2024-06-25
Drug substance claim: No
Drug product claim: No
Assignee: Nanjing Chia Tai Tianqing Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.